The catalepsy test: its ups and downs.

No abstract is available for this paper.

• Publication year

  1988

• Venue

  Behavioral Neuroscience

• Publication date

  1988-10-01

• Fields of study

  Biology, Medicine, Psychology

• Identifiers
  DOI 10.1037//0735-7044.102.5.748PMID 2904271
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• LEARNING IN TO ~ RANCE TO HALOPERIDOL-INDUCED CATALEPSY

  2018cited by this paper
• Potentiation of catalepsy induced by narcotic agents during Haffner's test for analgesia

  2004cited by this paper
• Parametric influences on catalepsy

  2004cited by this paper
• Evidence for a cholinergic role in haloperidol-induced catalepsy

  2004cited by this paper
• Cholinergic-dopaminergic interactions in experimental catalepsy

  2004cited by this paper
• Subsensitivity to muscimol-induced catalepsy after long-term administration of phenytoin in rats

  2004cited by this paper
• Effect of sensory stimulation on the potency of cataleptogens

  2004cited by this paper
• Experimental catalepsy is both enhanced and disrupted by apomorphine

  2004cited by this paper
• Effect of intraperitoneally administered GABA on haloperidol-induced catalepsy in the rat

  2004cited by this paper
• Chronic treatment with dopamine receptor antagonists: behavioral and pharmacologic effects on D1 and D2 dopamine receptors

  1988cited by this paper
• Quinolinic acid lesions of rat striatum abolish D1- and D2-dopamine receptor-mediated catalepsy.

  1988cited by this paper
• Effects of chronic SCH23390 treatment on the biochemical and behavioral properties of D1 and D2 dopamine receptors: potentiated behavioral responses to a D2 dopamine agonist after selective D1 dopamine receptor upregulation.

  1986cited by this paper
• Haloperidol in large doses reduces the cataleptic response and increases noradrenaline metabolism in the brain of the rat.

  1985cited by this paper
• Selective D-1 dopamine receptor increase following chronic treatment with SCH 23390.

  1985cited by this paper
• Morphine catalepsy as an adaptive reflex state in rats.

  1984cited by this paper
• Clinical Chemistry: Theory, Analysis, and Correlation

  1984cited by this paper
• The role of the GABA mechanisms of the globus pallidus in mediating catalepsy, stereotypy and locomotor activity.

  1984cited by this paper
• Scientific approaches to Huntington's disease.

  1984cited by this paper
• Acute and chronic effects of estrogen treatment on pimozide-induced catalepsy in the rat.

  1983cited by this paper
• SCH 23390, a potential benzazepine antipsychotic with unique interactions on dopaminergic systems.

  1983cited by this paper
• Tolerance and reverse tolerance to haloperidol catalepsy induced by the difference of administration interval in mice.

  1982cited by this paper
• Unilateral injection of morphine into the nucleus accumbens induces akinesia and catalepsy, but no spontaneous muscular rigidity in rats

  1982cited by this paper
• Alterations in drug induced catalepsy and post-decapitation convulsions following brain and spinal cord depletion of norepinephrine by the neurotoxin DSP-4.

  1982cited by this paper
• Glutamic acid diethyl ester induces catalepsy in rats. A new model for schizophrenia?

  1982cited by this paper
• Biphasic dose-response effect of baclofen on haloperidol catalepsy in the rat.

  1982cited by this paper
• Neurochemical aspects of the opioid-induced 'catatonia'.

  1982cited by this paper
• Hypokinesia in mice and catalepsy in rats elicited by morphine associated with antidopaminergic agents, including atypical neuroleptics.

  1981cited by this paper
• Involvement of caudate nucleus, amygdala or reticular formation in neuroleptic and narcotic catalepsy.

  1981cited by this paper
• Genetic predisposition to catatonic behaviour and methylphenidate sensitivity in rats.

  1981cited by this paper
• Tetrahydrocannabinol potentiates reserpine-induced hypokinesia.

  1981cited by this paper
• Cerebrospinal fluid homovanillic acid patterns during neuroleptic treatment.

  1981cited by this paper
• Effects of striatal lesions with kainic acid on morphine-induced “catatonia” and increase of striatal dopamine turnover

  1981cited by this paper
• Kainic acid injections in the striatum alter the cataleptic and locomotor effects of drugs influencing dopaminergic and cholinergic systems.

  1981cited by this paper
• Pinch-induced catalepsy in mice.

  1981cited by this paper
• Body pinch induces long lasting cataleptic like immobility in mice: behavioral characterization and the effect of naloxone.

  1981cited by this paper
• Relevance of the rodent area postrema to dopamine‐dependent behavioural effects

  1981cited by this paper
• (RS)-α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid: Wet dog shakes, catalepsy and body temperature changes in rats

  1981cited by this paper
• Increased amphetamine stereotypy and longer haloperidol catalepsy in spontaneously hypertensive rats.

  1981cited by this paper
• Stress induced facilitation of opiate catalepsy in the rat.

  1980cited by this paper
• Haloperidol-induced catalepsy is mediated by postsynaptic dopamine receptors

  1980cited by this paper
• Tissue levels of haloperidol by radioreceptor assay and behavioral effects of haloperidol in the rat.

  1980cited by this paper
• The development of catalepsy in drug-free mice on repeated testing.

  1980cited by this paper
• Biphasic effects of direct, but not indirect, GABA mimetics and antagonists on haloperidol-induced catalepsy

  1980cited by this paper
• Experimental influences on catalepsy.

  1980cited by this paper
• Is dopamine antagonism a requisite of neuroleptic activity?

  1980cited by this paper
• Morphine versus haloperidol catalepsy in the rat: a behavioral analysis of postural support mechanisms.

  1980cited by this paper
• Predictability and specificity of behavioral screening tests for neuroleptics.

  1979cited by this paper
• Serotonin--dopamine interactions in the nigrostriatal system.

  1979cited by this paper
• PRODUCTION OF CATALEPSY AND DEPLETION OF BRAIN MONOAMINES BY A BUTYROPHENONE DERIVATIVE

  1979cited by this paper
• On the central noradrenergic mechanism involved in haloperidol‐induced catalepsy in the rat

  1978cited by this paper
• Is morphine-induced catalepsy related to activation of dopaminergic neurones?

  1978cited by this paper
• GABA involvement in neuroleptic‐induced catalepsy

  1978cited by this paper
• Noradrenergic influences on catalepsy

  1978cited by this paper
• Effects of bilateral lesions in the striatum or nucleus accumbens on the cataleptogenic activity of neuroleptics in rats.

  1978cited by this paper
• Correlation between multitest and single test catalepsy assessment.

  1978cited by this paper
• Potentiation by haloperidol of the catalepsy produced by lesions in the parafascicular nucleus of the rat.

  1978cited by this paper
• The role of the corpus striatum in neuroleptic- and narcotic-induced catalepsy.

  1978cited by this paper
• Behavioural dissociation of the enkephalinergic systems of nucleus accumbens and nucleus caudatus.

  1977cited by this paper
• Tolerance of haloperidol catalepsy.

  1977cited by this paper
• Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs.

  1976cited by this paper
• Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs

  1976cited by this paper
• Correlation between catalepsy and dopamine decrease in the rat striatum induced by neuroleptics.

  1976cited by this paper
• The Basal ganglia

  1976cited by this paper
• Antipsychotic drug doses and neuroleptic/dopamine receptors

  1976cited by this paper
• Interaction of drug effects with testing procedures in the measurement of catalepsy.

  1976cited by this paper
• On catalepsy and catatonia and the predictability of the catalepsy test for neuroleptic activity

  1974cited by this paper
• Morphine catalepsy in the rat: relation to striatal dopamine metabolism.

  1972cited by this paper
• Cholinergic- and neuroleptic-induced catalepsy: modification by lesions in the caudate-putamen.

  1971cited by this paper
• Pharmacology and Therapeutics

  1963cited by this paper

• Striatal Nitric Oxide Activity Better Predicts Motor Disability Than Proto‐Oncogenes

  2026influential citation
• Design, characterization and evaluation of a novel dosage form of rebamipide as transdermal patches in rodent model of Parkinson’s disease

  2026cites this paper
• Optimization and Evaluation of Functionally Engineered Paliperidone Nanoemulsions for Improved Brain Delivery via Nasal Route.

  2025cites this paper
• In vitro, in vivo and in silico assessment of bioresorbable PLGA-PEG-PLGA based thermosensitive hydrogel mediated 30-days delivery of Lurasidone HCl for schizophrenia.

  2025cites this paper
• Preventive beneficial effects of cannabidiol in a reserpine-induced progressive model of parkinsonism

  2025cites this paper
• Effects of tropicamide on catalepsy and motor function in a mouse model of Parkinson’s disease

  2025cites this paper
• Curcumin treatment reduces motor impairments and protects against rotenone-induced neurodegeneration in a rat model of Parkinson disease

  2025cites this paper
• Plant-Derived Monoterpene Therapies in Parkinson’s Disease Models: Systematic Review and Meta-Analysis

  2025cites this paper
• Ameliorative Effects of Micronised Purified Flavonoid Fraction on Haloperidol-Induced Motor Impairments and Oxidative Stress in Female Wistar Rats

  2025cites this paper
• Synergistic effects of biosynthesized gold nanoparticles with curcumin on motor, inflammatory, and oxidative parameters in a Parkinson's disease model.

  2025cites this paper
• In situ-gelling hydrophobized starch nanoparticle-based nanoparticle network hydrogels for the effective delivery of intranasal olanzapine to treat brain disorders.

  2024cites this paper
• Effects of Intracerebral Aminophylline Dosing on Catalepsy and Gait in an Animal Model of Parkinson’s Disease

  2024cites this paper
• Tolperisone hydrochloride improves motor functions in Parkinson's disease via MMP-9 inhibition and by downregulating p38 MAPK and ERK1/2 signaling cascade.

  2024cites this paper
• Neuroprotective effects of punicalagin and/or micronized zeolite clinoptilolite on manganese‐induced Parkinson's disease in a rat model: Involvement of multiple pathways

  2024cites this paper
• Experimental models of Parkinson's disease: Challenges and Opportunities.

  2024cites this paper
• Systematic Approach in the Development of Chitosan Functionalized Iloperidone Nanoemulsions for Transnasal Delivery, In Vitro and In Vivo Studies

  2024cites this paper
• A sex-specific effect of M4 muscarinic cholinergic autoreceptor deletion on locomotor stimulation by cocaine and scopolamine

  2024cites this paper
• Orally administered Cannabigerol (CBG) in rats: Cannabimimetic actions, anxiety-like behavior, and inflammation-induced pain.

  2024cites this paper
• Isolation and structure elucidation of cyclohexanepentol, an anti-psychotic agent from Cissampelos owarensis (P. Beauv.) leaves

  2023cites this paper
• Genetic effects in a progressive model of parkinsonism induced by reserpine

  2023cites this paper
• Extrapyramidal Side Effects with Chronic Atypical Antipsychotic Can Be Predicted by Labeling Pattern of FosB and phosphoThr34-DARPP-32 in Nucleus Accumbens

  2023influential citation
• Conditioned Catalepsy vs. Increase in Locomotor Activity Induced by Haloperidol.

  2023cites this paper
• Botany, traditional usages, phytochemistry, pharmacology, and toxicology of Guilandina bonduc L.: a systematic review

  2023cites this paper
• Impact of early-life lead exposure on adult delta-9-tetrahydrocannabinol sensitivity in male and female C57BL6/J mice.

  2023cites this paper
• An Analysis of Genetic Predisposition to Hereditary Catalepsy in a Mouse Model of Neuropsychiatric Disorders Using Whole-Genome Sequencing Data

  2023cites this paper
• The Natural Protoalkaloid Methyl-2-Amino-3-Methoxybenzoate (MAM) Alleviates Positive as well as Cognitive Symptoms in Rat and Mouse Schizophrenia Models

  2023cites this paper
• Paradoxical kinesia may no longer be a paradox waiting for 100 years to be unraveled

  2023cites this paper
• SCH23390 and a humanized anti-cocaine mAb decrease the latency to cocaine-induced reinstatement of lever pressing behavior in rats that self-administer cocaine

  2023cites this paper
• Receptor mechanisms underlying the CNS effects of cannabinoids: CB1 receptor and beyond.

  2022cites this paper
• Anti-cataleptic, skeletal muscle relaxant and cognitive properties of the ethanol extract of Lophira alata Banks ex C.F. Gaertn. (Ochnaceae) stem bark in mice

  2022cites this paper
• Brain-Targeted Intranasal Delivery of Zotepine Microemulsion: Pharmacokinetics and Pharmacodynamics

  2022cites this paper
• The potent α2-adrenoceptor antagonist RS 79948 also inhibits dopamine D2 -receptors: Comparison with atipamezole and raclopride.

  2022cites this paper
• Effects of Immediate Aversive Stimulation on Haloperidol-Induced Catalepsy in Rats

  2022cites this paper
• Cannabinoid receptor 1 antagonist genistein attenuates marijuana-induced vascular inflammation.

  2022cites this paper
• Targeted activation of midbrain neurons restores locomotor function in mouse models of parkinsonism

  2022cites this paper
• Title: Neuroprotective repositioning and anti-tau effect of carvedilol on rotenone induced neurotoxicity in rats: Insights from an insilico&in vivo anti-Parkinson's disease study.

  2022cites this paper
• Targeted activation of midbrain neurons restores locomotor function in mouse models of parkinsonism

  2022cites this paper
• Female Rats Are Resistant to Cognitive, Motor and Dopaminergic Deficits in the Reserpine-Induced Progressive Model of Parkinson’s Disease

  2021cites this paper
• Effect of Adenosine A2a Receptor Antagonist In Haloperidol Induced Model of Parkinson’s Disease.

  2021cites this paper
• Cannabinoid tetrad effects of oral Δ9-tetrahydrocannabinol (THC) and cannabidiol (CBD) in male and female rats: sex, dose-effects and time course evaluations

  2021influential citation
• Endocannabinoid System Attenuates Oxaliplatin-Induced Peripheral Sensory Neuropathy Through the Activation of CB1 Receptors

  2021cites this paper
• Low protein diet: Its relevance to Manganese-induced neurotoxicity in rats treated with Coenzyme Q10 and/or Epigallocatechin-3-gallate.

  2021cites this paper
• Haloperidol‐induced catalepsy as an animal model for parkinsonism: A systematic review of experimental studies

  2021cites this paper
• Evaluation of Anti-Psychotic potential of Phytocompound rich Fractions of Methanolic extract of Lagenaria siceraria (Bottle Gourd) fruits in Murine Models of Schizophrenia

  2021cites this paper
• Translation of in vitro cannabinoid 1 receptor agonist activity to in vivo pharmacodynamic endpoints.

  2020cites this paper
• Discovery and Structure-activity Relationships of Nociceptin Receptor Partial Agonists that Afford Symptom Ablation in Parkinson's Disease Models.

  2020cites this paper
• Effects of Doxycycline in Swiss Mice Predictive Models of Schizophrenia

  2020cites this paper
• Oral quetiapine treatment results in time-dependent alterations of recognition memory and brain-derived neurotrophic factor-related signaling molecules in the hippocampus of rats.

  2020cites this paper
• Playback of 50-kHz ultrasonic vocalizations overcomes psychomotor deficits induced by sub-chronic haloperidol treatment in rats

  2020cites this paper
• Effect of methonolic extract of Vitex negundo on haloperidol induced catalepsy in albino mice

  2020cites this paper
• An Open Source Automated Bar Test for Measuring Catalepsy in Rats

  2020influential citation
• Chronic oral treatment with risperidone impairs recognition memory and alters brain-derived neurotrophic factor and related signaling molecules in rats.

  2020cites this paper
• A COMPREHENSIVE REVIEW ON NEUROPHARMACOLOGICAL POTENTIAL OF ACORUS CALAMUS LINN

  2020cites this paper
• Balance alterations and reduction of pedunculopontine cholinergic neurons in early stages of parkinsonism in middle-aged rats.

  2020cites this paper
• Effects of the selective dopamine D3 receptor antagonist PG01037 on morphine-induced hyperactivity and antinociception in mice

  2020cites this paper
• Citrus limon (L.) Burm f. Essential Oil Has Anxiolytic and Sedative Properties by Modulating GABAA-Receptors

  2020cites this paper
• Mild traumatic brain injury exacerbates Parkinson's disease induced hemeoxygenase-2 expression and brain pathology: Neuroprotective effects of co-administration of TiO2 nanowired mesenchymal stem cells and cerebrolysin.

  2020cites this paper
• Behavioral, Biochemical and Histopathological effects of Standardised Pomegranate extract with Vinpocetine, Propolis or Cocoa in a rat model of Parkinson’s disease

  2020cites this paper
• Low frequency deep brain stimulation in the inferior colliculus ameliorates haloperidol-induced catalepsy and reduces anxiety in rats

  2020cites this paper
• Effect of M

  2020cites this paper
• Translational models of cannabinoid vapor exposure in laboratory animals

  2020cites this paper
• Antipsychotic effects of philenoptera cyanescens (schum. & thonn.) roberty (leguminosae) leaf extract and fractions against ketamine-induced psychosis in mice

  2020cites this paper
• Sex differences in the progressive model of parkinsonism induced by reserpine in rats

  2019cites this paper
• Cross-tolerance between nitric oxide synthase inhibition and atypical antipsychotics modify nicotinamide-adenine-dinucleotide phosphate-diaphorase activity in mouse lateral striatum

  2019cites this paper
• Chlorpyrifos Exposure Induces Parkinsonian Symptoms and Associated Bone Loss in Adult Swiss Albino Mice

  2019cites this paper
• CNS Safety Screening Under ICH S7A Guidelines Requires Observations of Multiple Behavioral Units to Assess Motor Function

  2019cites this paper
• Neurorestorative effects of sub-chronic administration of ambroxol in rodent model of Parkinson’s disease

  2019cites this paper
• Radiographic dose‐dependency study of loperamide effects on gastrointestinal motor function in the rat. Temporal relationship with nausea‐like behavior

  2019cites this paper
• Prophylactic neuroprotective propensity of Crocin, a carotenoid against rotenone induced neurotoxicity in mice: behavioural and biochemical evidence

  2019cites this paper
• Influence of aversive stimulation on haloperidol-induced catalepsy in rats

  2019cites this paper
• Cognitive and anxiety-like impairments accompanied by serotonergic ultrastructural and immunohistochemical alterations in early stages of parkinsonism.

  2019cites this paper
• BIOSYNTHESIS, CHARACTERIZATION AND ANTIPARKINSON ACTIVITY OF MAGNETITE-INDONESIAN VELVET BEANS (Mucuna pruriens L.) NANOPARTICLES

  2019cites this paper
• Targeting oxidative stress, acetylcholinesterase, proinflammatory cytokine, dopamine and GABA by eucalyptus oil (Eucalyptus globulus) to alleviate ketamine-induced psychosis in rats

  2019cites this paper
• Gnal haploinsufficiency causes genomic instability and increased sensitivity to haloperidol.

  2019cites this paper
• Bone loss in MPTP mouse model of Parkinson's disease is triggered by decreased osteoblastogenesis and increased osteoclastogenesis

  2019cites this paper
• Continuous measurement of locomotor activity during convalescence and acclimation in group-housed rats

  2019cites this paper
• Prior exercise protects against oxidative stress and motor deficit in a rat model of Parkinson’s disease

  2019cites this paper
• Rebamipide Mitigates Impairments in Mitochondrial Function and Bioenergetics with α-Synuclein Pathology in 6-OHDA-Induced Hemiparkinson’s Model in Rats

  2019cites this paper
• A window into the brain: Tools to assess pre-clinical efficacy of biomaterials-based therapies on central nervous system disorders.

  2019cites this paper
• Brain targeting stealth lipomers of combined antiepileptic-anti-inflammatory drugs as alternative therapy for conventional anti-Parkinson’s

  2019cites this paper
• Protective effect of vinpocetine against neurotoxicity of manganese in adult male rats

  2018cites this paper
• Carvacrol prevents impairments in motor and neurochemical parameters in a model of progressive parkinsonism induced by reserpine.

  2018cites this paper
• The Effect of Caloric Res triction and Treadmill Exercise on Reserpine-Induced Catalepsy in a Rat Model of Parkinson’s Disease

  2018cites this paper
• Endogenous Neuronal Replacement in the Juvenile Brain Following Cerebral Ischemia.

  2018cites this paper
• Effects of the monoamine stabilizer (−)-OSU6162 on locomotor and sensorimotor responses predictive of antipsychotic activity

  2018cites this paper
• The Effect of Caloric Restriction and Treadmill Exercise on Reserpine-Induced Catalepsy in a Rat Model of Parkinson's Disease

  2018cites this paper
• Ambroxol modulates 6‐Hydroxydopamine‐induced temporal reduction in Glucocerebrosidase (GCase) enzymatic activity and Parkinson's disease symptoms

  2018cites this paper
• UJI TOKSISITAS SUBKRONIK EKSTRAK HERBA CIPLUKAN (Physalis angulata L.) TERHADAP PARAMETER BIOKIMIA DAN HISTOPATOLOGI GINJAL PADA TIKUS PUTIH (Rattus norvegicus) GALUR WISTAR

  2018cites this paper
• Differential behavioral and glial responses induced by dopaminergic mechanisms in the iNOS knockout mice

  2018cites this paper
• Glimepiride prevents paraquat‐induced Parkinsonism in mice: involvement of oxidative stress and neuroinflammation

  2018cites this paper
• Anti‐Parkinsonian and anti‐dyskinetic profiles of two novel potent and selective nociceptin/orphanin FQ receptor agonists

  2018cites this paper
• Synthesis of chiral GABAA receptor subtype selective ligands as potential agents to treat schizophrenia as well as depression.

  2018cites this paper
• Haloperidol–induced catalepsy is ameliorated by deep brain stimulation of the inferior colliculus

  2018cites this paper
• Neuroprotective effects of coenzyme Q10 on paraquat-induced Parkinson’s disease in experimental animals

  2018cites this paper
• Attenuation of motor deficits by hydroethanolic extract of Poincianella pyramidalis in a Parkinson’s disease model

  2017cites this paper
• Tangeretin inhibits neurodegeneration and attenuates inflammatory responses and behavioural deficits in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced Parkinson’s disease dementia in rats

  2017cites this paper
• A novel peptide that improves metabolic parameters without adverse central nervous system effects

  2017cites this paper
• 2′,3′-Dideoxycytidine Protects Dopaminergic Neurons in a Mouse Model of Parkinson’s Disease

  2017cites this paper
• Behavioral and neurochemical effects of alpha lipoic acid associated with omega-3 in tardive dyskinesia induced by chronic haloperidol in rats.

  2017cites this paper
• An Efficient Test Battery for Rapid Screening of Extrapyramidal Side-Effects of Phenothiazine Analogues

  2017influential citation